Covid-19: remdesivir and 3 other drugs “have little or no effect” on survival of patients, according to WHO

  • Drafting
  • BBC World News

Three hours


Remdesivir was one of the first drugs used in the treatment of covid-19

The antiviral drug remdesivir has little or no effect on the survival chances of hospitalized patients with COVID-19, according to a preliminary study by the World Health Organization (WHO) released Thursday.

The WHO trial, dubbed “Solidarity”, evaluated four possible drugs to treat covid-19, including remdesivir and the hidroxicloroquina.

Remdesivir was one of the first drugs to be used to treat the new coronavirus and was recently administered to the President of the United States, Donald Trump, when he was admitted to the hospital because of this disease.

Gilead, the drug’s maker, rejected the study’s conclusions.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.